The flavonolignans tested inhibit tumor angiogenesis biomarkers (nestin and CD31) and signaling angiogenesis molecules (VEGF, VEGFR1, VEGFR2, phospho-Akt, and HIF-1a) without affecting angiogenesis in normal healthy tissue. The gene discussed is VEGFA; the disease is neoplasm.